Empiric antimicrobial regimens for fever when profound (< 100/μL) granulocytopenia persists

Affiliations

Comment

Jai H Joshi. J Clin Oncol. 2014.

. 2014 Dec 1;32(34):3899.

doi: 10.1200/JCO.2014.56.9814. Epub 2014 Sep 15.

No abstract available

Comment in

Reply to J.H. Joshi.
Micozzi A, Bucaneve G, Gentile G. Micozzi A, et al. J Clin Oncol. 2014 Dec 1;32(34):3899-900. doi: 10.1200/JCO.2014.57.9243. Epub 2014 Sep 15. J Clin Oncol. 2014. PMID: 25225423 No abstract available.

Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.
Bucaneve G, Micozzi A, Picardi M, Ballanti S, Cascavilla N, Salutari P, Specchia G, Fanci R, Luppi M, Cudillo L, Cantaffa R, Milone G, Bocchia M, Martinelli G, Offidani M, Chierichini A, Fabbiano F, Quarta G, Primon V, Martino B, Manna A, Zuffa E, Ferrari A, Gentile G, Foà R, Del Favero A. Bucaneve G, et al. J Clin Oncol. 2014 May 10;32(14):1463-71. doi: 10.1200/JCO.2013.51.6963. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733807 Clinical Trial.